Effects of Podocyte Foot Process Effacement on Kidney Prognosis and Response to Immunosuppressive Therapy in IgA Nephropathy.

IF 3.4 Q1 UROLOGY & NEPHROLOGY
Kidney Medicine Pub Date : 2025-06-17 eCollection Date: 2025-08-01 DOI:10.1016/j.xkme.2025.101049
Yingman Guo, Yali Ren, Sufang Shi, Suxia Wang, Xujie Zhou, Lijun Liu, Jicheng Lv, Li Zhu, Hong Zhang
{"title":"Effects of Podocyte Foot Process Effacement on Kidney Prognosis and Response to Immunosuppressive Therapy in IgA Nephropathy.","authors":"Yingman Guo, Yali Ren, Sufang Shi, Suxia Wang, Xujie Zhou, Lijun Liu, Jicheng Lv, Li Zhu, Hong Zhang","doi":"10.1016/j.xkme.2025.101049","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale & objective: </strong>Recent studies have proposed that podocyte lesions within segmental glomerulosclerosis (S1) lesions are associated with kidney prognosis in immunoglobulin A nephropathy (IgAN). However, there is a lack of research exploring the effect of podocyte lesions through electron microscopy, which is currently regarded as the best power tool for evaluating podocyte injury, on kidney prognosis and response to immunosuppressive therapy (IST).</p><p><strong>Study design: </strong>An observational cohort study.</p><p><strong>Setting & participants: </strong>Total of 976 patients with IgAN and at least 12 months of follow-up at Peking University First Hospital.</p><p><strong>Exposure: </strong>Different foot process effacement (FPE) severity evaluated by electron microscopy: mild: <50%, moderate: 50%-74%, and severe: ≥75%.</p><p><strong>Outcome: </strong>A composite kidney outcome of a 50% reduction in the estimated glomerular filtration rate or end-stage kidney disease.</p><p><strong>Analytical approach: </strong>Cox proportional hazard models.</p><p><strong>Results: </strong>Moderate and severe FPE were independent risk factors for kidney outcome in overall cohort (severe: HR, 1.85; 95% CI, 1.22-2.80; <i>P</i> = 0.004; moderate: HR, 1.62; 95% CI, 1.00-2.62; <i>P</i> = 0.048; <i>P</i>-trend = 0.002). Patients with moderate FPE had a significantly increased risk of worse kidney outcome among those without IST (HR, 3.04; 95% CI, 1.52-6.09; <i>P</i> = 0.002), with risk being significantly reduced in those with IST (HR, 1.06; 95% CI, 0.51-2.23; <i>P</i> = 0.87). However, severe FPE was an independent risk factor for kidney prognosis in patients with IgAN regardless of receiving IST (without IST: HR, 2.13; 95% CI, 0.97-6.09; <i>P</i> = 0.06; with IST: HR, 1.80, 95% CI, 1.08-2.98; <i>P</i> = 0.02). The reclassification ability of the model was significantly improved with 1.7% of integrated discrimination improvements (95% CI, 0.1%-5.2%) and 0.37 of continuous net reclassification improvement (95% CI, 0.14-0.62) when integrating FPE into the International IgAN Prediction Tool.</p><p><strong>Limitations: </strong>A single-center observational study, selection bias, and unmeasured confounders.</p><p><strong>Conclusions: </strong>Moderate and severe FPE were independent risk factors affecting kidney prognosis in patients with IgAN. Podocyte injury evaluated by electron microscopy had important clinical value in IgA nephropathy.</p>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":"7 8","pages":"101049"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12309955/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xkme.2025.101049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale & objective: Recent studies have proposed that podocyte lesions within segmental glomerulosclerosis (S1) lesions are associated with kidney prognosis in immunoglobulin A nephropathy (IgAN). However, there is a lack of research exploring the effect of podocyte lesions through electron microscopy, which is currently regarded as the best power tool for evaluating podocyte injury, on kidney prognosis and response to immunosuppressive therapy (IST).

Study design: An observational cohort study.

Setting & participants: Total of 976 patients with IgAN and at least 12 months of follow-up at Peking University First Hospital.

Exposure: Different foot process effacement (FPE) severity evaluated by electron microscopy: mild: <50%, moderate: 50%-74%, and severe: ≥75%.

Outcome: A composite kidney outcome of a 50% reduction in the estimated glomerular filtration rate or end-stage kidney disease.

Analytical approach: Cox proportional hazard models.

Results: Moderate and severe FPE were independent risk factors for kidney outcome in overall cohort (severe: HR, 1.85; 95% CI, 1.22-2.80; P = 0.004; moderate: HR, 1.62; 95% CI, 1.00-2.62; P = 0.048; P-trend = 0.002). Patients with moderate FPE had a significantly increased risk of worse kidney outcome among those without IST (HR, 3.04; 95% CI, 1.52-6.09; P = 0.002), with risk being significantly reduced in those with IST (HR, 1.06; 95% CI, 0.51-2.23; P = 0.87). However, severe FPE was an independent risk factor for kidney prognosis in patients with IgAN regardless of receiving IST (without IST: HR, 2.13; 95% CI, 0.97-6.09; P = 0.06; with IST: HR, 1.80, 95% CI, 1.08-2.98; P = 0.02). The reclassification ability of the model was significantly improved with 1.7% of integrated discrimination improvements (95% CI, 0.1%-5.2%) and 0.37 of continuous net reclassification improvement (95% CI, 0.14-0.62) when integrating FPE into the International IgAN Prediction Tool.

Limitations: A single-center observational study, selection bias, and unmeasured confounders.

Conclusions: Moderate and severe FPE were independent risk factors affecting kidney prognosis in patients with IgAN. Podocyte injury evaluated by electron microscopy had important clinical value in IgA nephropathy.

Abstract Image

Abstract Image

Abstract Image

足细胞足突消退对IgA肾病患者肾脏预后及免疫抑制治疗反应的影响。
理由与目的:最近的研究表明,免疫球蛋白A肾病(IgAN)患者节段性肾小球硬化(S1)病变内足细胞病变与肾脏预后相关。然而,目前缺乏通过电子显微镜研究足细胞病变对肾脏预后和免疫抑制治疗(IST)反应的影响的研究,而电子显微镜被认为是评估足细胞损伤的最佳有力工具。研究设计:观察性队列研究。环境和参与者:共976例IgAN患者,在北京大学第一医院随访至少12个月。暴露:不同的足突淡化(FPE)严重程度通过电子显微镜评估:轻度;结局:肾小球滤过率估计减少50%或终末期肾病的复合肾脏结局。分析方法:Cox比例风险模型。结果:在整个队列中,中度和重度FPE是肾脏预后的独立危险因素(重度:HR, 1.85;95% ci, 1.22-2.80;p = 0.004;中度:HR, 1.62;95% ci, 1.00-2.62;p = 0.048;P-trend = 0.002)。与没有IST的患者相比,中度FPE患者肾脏预后恶化的风险显著增加(HR, 3.04;95% ci, 1.52-6.09;P = 0.002), IST组风险显著降低(HR, 1.06;95% ci, 0.51-2.23;p = 0.87)。然而,严重FPE是IgAN患者肾脏预后的独立危险因素,无论是否接受IST(未接受IST: HR, 2.13;95% ci, 0.97-6.09;p = 0.06;与IST: HR, 1.80, 95% CI, 1.08-2.98;p = 0.02)。当将FPE整合到国际IgAN预测工具中时,模型的再分类能力显著提高,综合判别改善1.7% (95% CI, 0.1%-5.2%),连续净再分类改善0.37 (95% CI, 0.14-0.62)。局限性:单中心观察性研究、选择偏倚和未测量的混杂因素。结论:中度和重度FPE是影响IgAN患者肾脏预后的独立危险因素。电镜观察足细胞损伤对IgA肾病有重要的临床价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信